BioMarin Pharmaceutical Inc.: BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and ...

BioMarin to Gain Galafold® (migalastat) for Fabry Disease and Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) for Pompe Disease, Adding Two Marketed, High-Growth Products with ...

Destination XL Group and FullBeauty Brands to Combine in Merger of Equals, Creating a Scaled, Category-Defining Retailer for Inclusive Apparel

Creating One of the Largest Omni-Channel Retailers Across the Full Inclusive Sizing Market, with Approximately $1.2 Billion of Combined Annual ...
The Nation Newspaper

JADC 3.0: Jendol’s Education Revolution Shines as 14-Year-Old Ndubuisi Praise Emerges Debate Champion

THE NATION; In a thrilling display of intellect, eloquence, and youthful brilliance, 14-year-old Ndubuisi Praise of Community ...
Le Lézard

Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction

STAAR Surgical Company , the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICLtm) for vision correction, today reported that independent industry analysts have ...
Le Lézard

STAAR Surgical Sets the Record Straight Regarding its Robust Go-Shop Process

STAAR Surgical Company , the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICLtm) for vision correction, today issued the following statement to correct ...
Frontiers

Bridging Growth and Dysfunction: Insights into Pulmonary Development and Disease

Lung development begins during embryogenesis and continues after birth. It includes branching of airways, formation of ...

BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) and Amicus Therapeutics (Nasdaq: FOLD) announced today that BioMarin has entered into a definitive agreement to acquire Amicus for $14.50 per share in an ...
Forbes

3 Best Growth Stocks To Buy In 2026

Forbes contributors publish independent expert analyses and insights. Peter Cohan, a Boston-based senior contributor, covers stocks. The top growth stock picks for 2026 include shares in companies ...
The Motley Fool

3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term

Investing in leading growth stocks can lead to large gains. For more than a decade now, growth stocks have been the driving force behind the market's run higher. As long as the bull market lasts, that ...
The Motley Fool

3 Growth ETFs to Buy With $5,000 and Hold Forever

The Vanguard Growth ETF has been a significant market beater. The Invesco QQQ Trust is heavily tech focused and can sometimes be volatile, but returns have been impressive. The Schwab U.S. Large-Cap ...
24/7 Wall St

3 Dividend Growth ETFs That Offer Good Yields And Long-Term Gains

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Dividend growth stocks have a simple premise. Get low ...

New Growth Theory: Definition, Importance, and Impact on Economic Growth

Discover how New Growth Theory drives economic growth through innovation and entrepreneurship, emphasizing knowledge as a limitless asset for productivity.